What is Evommune 's purchase obligation?

Evommune (EVMN) reported purchase obligation of $725K in Q1 2026.

What does purchase obligation mean?

This represents the total value of legally binding, non-cancelable commitments to acquire goods or services from third-party vendors in future periods. It provides visibility into the company's upcoming operational cash requirements and long-term supply chain or research service dependencies. Tracking these obligations is vital for evaluating liquidity risk and the company's ability to meet future contractual commitments.

Evommune EVMN Purchase Obligation

Purchase Obligation at other companies

Hims & Hers HealthHIMS

——

Other financials

Income statement

See full

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

See full

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

See full

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

See full

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

See full

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

See full

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:ContractualObligation.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's purchase obligation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evommune 's purchase obligation?: Evommune (EVMN) reported purchase obligation of $725K in Q1 2026.
What does purchase obligation mean?: This represents the total value of legally binding, non-cancelable commitments to acquire goods or services from third-party vendors in future periods. It provides visibility into the company's upcoming operational cash requirements and long-term supply chain or research service dependencies. Tracking these obligations is vital for evaluating liquidity risk and the company's ability to meet future contractual commitments.